Close
More
 
 

Join Now

It's Free - Always

First Name
 
Last Name
 
Zip/Postal Code
 
Country of Practice
 
 
 
Specialty
Email
 
Password
 
Confirm Password
 
Terms
I have read and agree to the Participant Terms and Conditions
 
 
 

is already registered on QuantiaMD

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Forgot your password? Click here and password reset instructions will be sent to the above email address.
Need more help? Contact Member Support
 
 

is already registered on QuantiaMD

 
 
Instructions to reset your password have been sent to the following email address:

For further assistance, please Contact Member Support
Thank you for registering on QuantiaMD.

Forgot your password?

Please enter your email address below, and we will send you a link to reset your password.

Submit
Earn this Certificate
0%
0 out of 9 completed
Advances in the Treatment of Hepatitis C

Now is an especially exciting time in the management of HCV. May 2011 introduced two new drugs—the first direct-acting agents that specifically block the lifecycle of HCV—but with the introduction of these exciting new drugs come new challenges. In this Expert Practice Series, Dr. Thomas and his esteemed faculty will navigate you through this new and challenging landscape.

Moderated By:
David Thomas, MD, MPH
Chief, Division of Infectious Diseases, Johns Hopkins School of Medicine
Start the next presentation
You've completed 0 out of 9 presentations
 
Expert Practice Series Presentations
David Thomas, MD, MPH
Chief, Division of Infectious Diseases, Johns Hopkins School of Medicine
(350)
64 Comments
David L. Wyles, MD
Division of Infectious Diseases, University of California, San Diego
(1,020)
218 Comments
Eliot Godofsky, MD, FACP
Co-founder and President, Bach and Godofsky, Director, University Hepatitis Center
(970)
214 Comments
Susanna Naggie, MD
Assistant Professor of Medicine, Department of Internal Medicine, Duke University Medical Center
(2,406)
548 Comments
Mark Sulkowski, MD
Professor of Medicine, Johns Hopkins University School of Medicine, Medical Director, Viral Hepatitis Center
(703)
165 Comments
Charles W. Flexner, MD
Professor of Medicine, Pharmacology, and International Health, Deputy Director, Institute for Clinical and Translational Research, Johns Hopkins University
(146)
24 Comments
Alain H. Litwin, MD, MPH
Associate Professor of Clinical Medicine and Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center
(1,694)
299 Comments
David Thomas, MD, MPH
Chief, Division of Infectious Diseases, Johns Hopkins School of Medicine
(1,466)
485 Comments
Eliot Godofsky, MD, FACP
Co-founder and President, Bach and Godofsky, Director, University Hepatitis Center
(226)
37 Comments
Latest Comments
"thank goodness for the new DAA - great presentation"
Richard Woller, PA-C
Physician Assistant, Gastroenterology Professional Services
548 Comments
"this information is interesting, but mute with the introduction of new HepC DAA."
Richard Woller, PA-C
Physician Assistant, Gastroenterology Professional Services
214 Comments
 
Terms | Privacy | FAQ | support@quantiamd.com | 1-800-773-4162
©2016 Quantia, a wholly owned subsidiary of Aptus Health, Inc.
 
Version 2.13.40.12